- Filed
- Jul 14, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $767.18K |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $917.24K |
| Cash And Equivalents | Q1 2021 · Mar 31, 2020 | $1.23M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2019 | $25K |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $1.64M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $1.13M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $27.86M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $40.48M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $872.75K |
| Current Assets | Q1 2021 · Dec 31, 2020 | $978.66K |
| Total Assets | Q1 2021 · Mar 31, 2021 | $231.43M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $231.53M |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$227.45K |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | $5M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | $3.79K |
| Sga Expense restated | Q1 2021 · Mar 31, 2020 | $1.59M |
| Net Income restated | Q1 2021 · Mar 31, 2020 | $12.02M |
| Operating Income restated | Q1 2021 · Mar 31, 2020 | −$1.62M |